Anil Vachani, MD, MS

faculty photo
Associate Professor of Medicine at the Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center
Attending Physician, Philadelphia Veterans Administration Medical Center
Director of Clinical Research, Section of Interventional Pulmonology and Thoracic Oncology, Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine
Director of Bronchoscopy, Philadelphia VA Medical Center
Director, Lung Nodule Program, Perelman School of Medicine, Univeristy of Pennsylvania
Associate Director, Masters in Translational Research Program, ITMAT Educational Programs, Perelman School of Medicine, University of Pennsylvania
Co-Director Lung Cancer Screening Program, Perelman School of Medicine, University of Pennslvania
Department: Medicine

Contact information
Pulmonary, Allergy, and Critical Care Division
University of Pennsylvania School of Medicine
Suite 216, Stemmler Hall
3450 Hamilton Walk
Philadelphia, PA 19104
Office: 215.573.7931
B.A. (Economics)
University of California, Berkeley, 1992.
B.S. (Genetics)
University of California, Berkeley, 1992.
M.D. (Medicine)
University of California, San Francisco, 1996.
M.S. (Clinical Epidemiology)
University of Pennsylvania, Perelman School of Medicine, 2013.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Kim RY, Oke JL, Pickup LC, Munden RF, Dotson TL, Bellinger CR, Cohen A, Simoff MJ, Massion PP, Filippini C, Gleeson FV, Vachani A.: Artificial Intelligence Tool for Assessment of Indeterminate Pulmonary Nodules Detected with CT. Radiology May 2022.

Schapira MM, Chhatre S, Prigge JM, Meline J, Kaminstein D, Rodriguez KL, Fraenkel L, Kravetz JD, Whittle J, Bastian LA, Vachani A, Akers S, Schrand S, Ibarra JV, Asan O.: A Veteran-Centric Web-Based Decision Aid for Lung Cancer Screening: Usability Analysis. JMIR Form Res 6: e29039, Apr 2022.

Chhatre S, Murgu S, Vachani A, Jayadevappa R.: Photodynamic therapy for stage I and II non-small cell lung cancer: A SEER-Medicare analysis 2000-2016. Medicine (Baltimore) 101: e29053, Mar 2022.

Thompson JC, Aggarwal C, Wong J, Nimgaonkar V, Hwang WT, Andronov M, Dibardino DM, Hutchinson CT, Ma KC, Lanfranco A, Moon E, Haas AR, Singh AP, Ciunci CA, Marmarelis M, D'Avella C, Cohen JV, Bauml JM, Cohen RB, Langer CJ, Vachani A, Carpenter EL: Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study. JTO Clin Res Rep 3(4): 100301, Mar 2022.

Kim RY, Rendle KA, Mitra N, Saia CA, Neslund-Dudas C, Greenlee RT, Burnett-Hartman AN, Honda SA, Simoff MJ, Schapira MM, Croswell JM, Meza R, Ritzwoller DP, Vachani A: Racial Disparities in Adherence to Annual Lung Cancer Screening and Recommended Follow-up Care: A Multicenter Cohort Study. Ann Am Thorac Soc Feb 2022.

Ritzwoller DP, Meza R, Carroll NM, Blum-Barnett E, Burnett-Hartman AN, Greenlee RT, Honda SA, Neslund-Dudas C, Rendle KA, Vachani A.: Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems. JAMA Netw Open 4: e2128176, Oct 2021.

Kim RY, Li Y, Marmarelis ME, Vachani A.: Comparative effectiveness of second-line immune checkpoint inhibitor therapy versus chemotherapy for malignant pleural mesothelioma. Lung Cancer 159: 107-110, Sep 2021 Notes: doi: 10.1016/j.lungcan.2021.06.017.

Vachani A, Maldonado F, Laxmanan B, Kalsekar I, Murgu S.: The Impact of Alternative Approaches to Diagnostic Yield Calculation in Studies of Bronchoscopy. Chest Page: Online ahead of print, Sep 2021 Notes: doi: 10.1016/j.chest.2021.08.074.

Burnett-Hartman AN, Carroll NM, Honda SA, Joyce C, Mitra N, Neslund-Dudas C, Olaiya O, Rendle KA, Schnall MD, Vachani A, Ritzwoller DP.: Community-based Lung Cancer Screening Results in Relation to Patient and Radiologist Characteristics: the PROSPR Consortium. Ann Am Thorac Soc Page: Online ahead of print, Sep 2021 Notes: doi: 10.1513/AnnalsATS.202011-1413OC.

Kim RY, Mitra N, Bagley SJ, Marmarelis ME, Haas AR, Rendle KA, Vachani A.: Immune Checkpoint Inhibitor Uptake in Real-World Patients With Malignant Pleural Mesothelioma. JTO Clinical and Research Reports 2(6): 100188, Jun 2021.

back to top
Last updated: 06/06/2022
The Trustees of the University of Pennsylvania